Prelude Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $288K | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.32M | Buy |
|
|||||
|
2023
Q1 | $1.43M | Buy |
|
|||||
|
2022
Q4 | $1.52M | Buy |
|
|||||
|
2022
Q3 | $306K | Sell |
|
|||||
|
2022
Q2 | $811K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $623K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $515K | Buy |
|
|||||
|
2020
Q1 | $251K | Sell |
|
|||||
|
2019
Q4 | $824K | Buy |
|
|||||
|
2019
Q3 | $6K | Sell |
|
|||||
|
2019
Q2 | $996K | Buy |
|
|||||
|
2019
Q1 | $430K | Buy |
|
|||||
|
2018
Q4 | $310K | Sell |
|
|||||
|
2018
Q3 | $692K | Buy |
|
|||||
|
2018
Q2 | $413K | Buy |
|
|||||
|
2018
Q1 | $347K | Sell |
|
|||||
|
2017
Q4 | $913K | Buy |
|
|||||
|
2017
Q3 | $232K | Sell |
|
|||||
|
2017
Q2 | $479K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $240K | Buy |
|
|||||
|
2016
Q3 | $188K | Sell |
|
|||||
|
2016
Q2 | $387K | Sell |
|
|||||
|
2016
Q1 | $525K | Sell |
|
|||||
|
2015
Q4 | $1.06M | Buy |
|
|||||
|
2015
Q3 | $909K | Sell |
|
|||||
|
2015
Q2 | $1.31M | Sell |
|
|||||
|
2015
Q1 | $1.28M | Buy |
|
|||||
|
2014
Q4 | $347K | Sell |
|
|||||
|
2014
Q3 | $373K | Buy |
|
|||||
|
2014
Q2 | $251K | Sell |
|
|||||
|
2014
Q1 | $554K | Buy |
|
|||||
|
2013
Q4 | $356K | Hold |
|
|||||
|
2013
Q3 | $365K | Sell |
|
|||||
|
2013
Q2 | $709K | Buy |
|